Riskpilot← Back to searchSign inGet full accessBGI EUROPE A/S
A/SActiveCVR 32931340Symfonivej 34Research and experimental development on natural sciences and engineering · NACE 7210Est. 20105 employees
Revenue 2024
DKK 1,2M
-97% vs 2023
EBITDA margin
-744.4%
-137% vs 2023
Equity ratio
16.6%
Financial strength
Net profit 2024
DKK -15,7M
-209% vs 2023
| Revenue | DKK 1,2M | -97% |
| EBITDA | DKK -9,2M | -137% |
| Net profit | DKK -15,7M | -209% |
| Total assets | DKK 182,2M | -5% |
| Equity | DKK 30,3M | -34% |
| Employees | 5 | — |
Legal name
BGI EUROPE A/S
CVR number
32931340
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
17. maj 2010
Share capital
DKK 6.000.000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af 2 medlemmer af bestyrelsen i forening, af direktionen alene eller af bestyrelsesformanden alene.
Company purpose
Selskabets formål er at drive virksomhed med forskning, teknologisk udvikling, produktudvikling, produktion og markedsføring indenfor medicinalsektoren, herunder indenfor biovidenskab, laboratorieservices, herunder gentestning, bioteknologi, bio-information og sundhedspleje samt hertil relateret virksomhed
Address
Symfonivej 34
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 18.745 | -90.404 | 53.346 | 35.444 | 1.236 |
| Staff expenses | -9.705 | -10.799 | -11.595 | -10.336 | -10.437 |
| EBITDA | 9.040 | -101.203 | 41.750 | 24.980 | -9.201 |
| Depreciation & amort. | -4.200 | -3.689 | -4.479 | -5.179 | -10.523 |
| EBIT | 4.841 | -104.892 | 37.271 | 19.800 | -19.724 |
| Net financials | -2.753 | 326 | -4.507 | -485 | -620 |
| Profit before tax | 2.088 | -104.565 | 32.764 | 19.315 | -20.344 |
| Tax | -687 | -24.708 | 7.738 | 4.859 | -4.649 |
| Net profit | 2.775 | -79.858 | 25.026 | 14.457 | -15.695 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 219.956 | 427.143 | 220.578 | 192.298 | 182.224 |
| Equity | 86.330 | 6.473 | 31.499 | 45.956 | 30.260 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 82.162 | 398.935 | 165.993 | 119.392 | 120.424 |
| Total debt | 133.351 | 420.670 | 189.079 | 146.342 | 151.963 |
EBITDA margin
-744.4%
This company
15.8%
Market median
-4811% vs market
20202024
Equity ratio
16.6%
This company
38.2%
Market median
-57% vs market
20202024
Return on equity
-51.9%
This company
18.4%
Market median
-382% vs market
20202024
Net profit margin
-1269.8%
This company
8.1%
Market median
-15777% vs market
20202024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20202024
Debt / equity
5.02×
This company
0.62×
Market median
-710% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JC Management | Management | 2025 |
PM Founder | Founder | 2010 |
| Former (2) | ||
RX Management | Management | 2022 – 2025 |
MF Chief Executive Officer | Chief Executive Officer | 2010 – 2011 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
HZ | Board of Directors | 2022 |
| Board of Directors | 2022 | |
NL | Chairman | 2022 |
| Former (6) | ||
| Chairman | 2010 – 2012 | |
| Board of Directors | 2010 – 2012 | |
| Board of Directors | 2012 – 2016 | |
| Board of Directors | 2017 – 2022 | |
| Board of Directors | 2012 – 2017 | |
| Chairman | 2012 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2015 | |
| Individual | 100% | 100% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BGI EUROPE A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ruiqi Xu | Management | 0 companies |
| JUN CHENG | Management | 0 companies |
| Man Fung Mak | Chief Executive Officer | 0 companies |
| Philip Martin Graff | Founder | 0 companies |
| Tong Zhang | Chairman | 0 companies |
| Songgang Li | Board of Directors | 0 companies |
| Yingrui Li | Board of Directors | 0 companies |
| Hao Zeng | Board of Directors | 0 companies |
| YU TAK KIN DUNCAN | Board of Directors | 0 companies |
| Shengquan Huang | Board of Directors | 0 companies |
| CAO Sujie | Board of Directors | 0 companies |
| Ning Li | Chairman | 0 companies |
| Jian Wang | Chairman | 0 companies |